2 min read
Grail's cancer blood test fails key NHS study, shares drop 47%
Grail's cancer blood test failed its main goal in a large NHS study, causing its stock to drop 47%.
7 articles
Grail's cancer blood test failed its main goal in a large NHS study, causing its stock to drop 47%.
Fish oil's cancer effects depend on an enzyme, ALOX15. Without it, supplements may not prevent colorectal tumors. EPA forms worked better than DHA in mice. Consult a doctor before use.
Scientists found the enzyme N4BP2 triggers chromothripsis, a catastrophic chromosome shattering that drives aggressive cancers. Blocking it could slow tumor evolution and drug resistance.
Northwestern scientists found that rearranging vaccine components at the nanoscale, without changing ingredients, can dramatically boost immune response against HPV-driven cancers, advancing structural nanomedicine.
A 2015 Nature article had a duplicated micrograph in a figure. The correction clarifies the error, provides the correct image, and states the study's conclusions remain unchanged.
ATF4 in cancer cells suppresses anti-tumor immunity by producing LCN2, which attracts immunosuppressive macrophages and excludes T cells. Blocking LCN2 boosts immune response.
An mRNA vaccine targeting neoantigens induced strong, long-lasting T cell responses in triple-negative breast cancer patients. Most remained cancer-free for years, with insights into why a few relapsed.